Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Human Technologies Inc. (5621:JPX), powered by AI.
Human Technologies Inc. is currently trading at ¥1,328. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Human Technologies Inc. on Alpha Lenz.
Human Technologies Inc.'s P/E ratio is 19.4.
“Human Technologies Inc. trades at a P/E of 19.4 (fair value) with strong ROE of 15.7%. 3Y revenue CAGR of 19.1% highlights clear growth momentum.”
Ask for details →Human Technologies Inc. is a leading provider of assistive technology solutions, focusing on enhancing accessibility and empowerment for individuals with disabilities. The company's primary function revolves around developing innovative devices and systems that aid users in communication, mobility, and daily life activities. These solutions are vital in sectors such as healthcare, education, and personal mobility, as they strive to improve the quality of life and independence of their users. Human Technologies Inc.'s product offerings include advanced hearing aids, communication devices, mobility aids, and specialized software applications tailored to individual needs. Its impact spans across healthcare facilities, educational institutions, and rehabilitation centers, where its products are integral to patient care and support. With a commitment to research and development, Human Technologies Inc. plays a crucial role in the assistive technology market, continually advancing the standards of inclusivity and accessibility through cutting-edge technological breakthroughs.
“Human Technologies Inc. trades at a P/E of 19.4 (fair value) with strong ROE of 15.7%. 3Y revenue CAGR of 19.1% highlights clear growth momentum.”
Ask for details →Human Technologies Inc. (ticker: 5621) is a company listed on JPX in the Technology sector (Software - Infrastructure). It has approximately 318 employees. Market cap is $12.7B.
The current price is 1,328 with a P/E ratio of 19.44x and P/B of 2.87x.
ROE is 15.75% and operating margin is 15.38%. Annual revenue is $6.1B.